Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Wald...
Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström’s macroglobulinemia
About this item
Full title
Author / Creator
Publisher
Tokyo: Springer Japan
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: Springer Japan
Subjects
More information
Scope and Contents
Contents
Waldenström’s macroglobulinemia is rare lymphoproliferative disorder characterized by the presence of a monoclonal IgM paraproteinemia. Cryoglobulinemia is a common sequela of Waldenström’s macroglobulinemia present in 8–18% of the patients. Cryoglobulinemia has also been described as occurring after treatment with rituximab. In the previous report...
Alternative Titles
Full title
Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström’s macroglobulinemia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_218150948
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_218150948
Other Identifiers
ISSN
1342-1751
E-ISSN
1437-7799
DOI
10.1007/s10157-008-0042-9
